Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine

Transfusion Medicine Reviews
Ching Y VossJames S Malter

Abstract

The encouraging results from dendritic cell-related cancer immunotherapy have created tremendous interest for its broad clinical application. Dendritic cells are the most potent antigen-presenting cells. In cancer patients, dendritic cell production and function along with other antitumor immune defenses are compromised. Autologous dendritic cells enriched and sensitized in vitro with tumor-associated antigens can effectively elicit host cellular immunity against cancer and result in clinical antitumor responses through either direct injection or ex vivo generation of antitumor T lymphocytes. In small group studies, clinical response rates have reached 50% in patients with advanced stage of cancer. These cellular products caused minimal side effects and were well tolerated. The isolation and preparation of clinical grade dendritic cells have been driven by transfusion medicine specialists who are well versed in similar processes for hematopoietic stem-cell preparation. The purpose of this article is to review the mechanisms of tumor immune surveillance and the biology of dendritic cells relevant to tumor antigen presentation, sensitization, and T-lymphocyte stimulation. Information on tumor-associated antigens and clinical tria...Continue Reading

Citations

Feb 5, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Amir-Hassan ZarnaniNazanin Mojtabavi
Mar 17, 2007·Annals of the New York Academy of Sciences·Shanjana Awasthi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Current Opinion in Pharmacology
Jenny Cook, Thorsten Hagemann
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Peter Brossart, Peter Brossart M D
© 2022 Meta ULC. All rights reserved